Tandem Diabetes Care, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $5.89M, a 18.07% decline year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $4.66M, a 21.15% decline year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $7.19M, a 14.44% increase year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $11.85M, a 2.80% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $12.20M, a 14.20% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $10.68M, a 16.00% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $12.71M, a 14.85% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $5.89M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $11.85M 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | $7.19M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $5.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $12.20M 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | $6.29M 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.68M 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $6.80M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $12.71M 10-K · filed 2025-02-26 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | |
| 2022-06-30 | $7.92M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $11.07M 10-K · filed 2024-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | |
| 2021-06-30 | $6.32M 10-Q · filed 2022-08-03 | |
| 2020-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $9.12M 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2020-06-30 | $4.92M 10-Q · filed 2021-08-04 | |
| 2019-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $6.21M 10-K · filed 2022-02-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | |
| 2019-06-30 | $2.95M 10-Q · filed 2020-07-30 | |
| 2018-12-31 | $1.36M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $300.00K 10-K · filed 2020-02-24 | |
| 2016-12-31 | $2.15M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $2.93M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $3.17M 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |